Voya Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Voya Investment Management LLC

  • $82.2 Billion
  • Q2 2025

A detailed history of Voya Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 699,644 shares of VRTX stock, worth $271 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
699,644
Previous 827,138 15.41%
Holding current value
$271 Million
Previous $401 Million 22.33%
% of portfolio
0.38%
Previous 0.56%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$421.16 - $509.5 $53.7 Million - $65 Million
-127,494 Reduced 15.41%
699,644 $311 Million
Q1 2025

May 15, 2025
BUY
$402.49 - $513.76 $51.7 Million - $66 Million
128,432 Added 18.38%
827,138 $401 Million
Q4 2024

Feb 14, 2025
SELL
$396.64 - $516.74 $94.9 Million - $124 Million
-239,345 Reduced 25.52%
698,706 $281 Million
Q3 2024

Feb 07, 2025
SELL
$460.0 - $505.78 $251 Million - $275 Million
-544,625 Reduced 36.73%
938,051 $436 Million
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $251 Million - $275 Million
-544,625 Reduced 36.73%
938,051 $436 Million
Q2 2024

Feb 07, 2025
BUY
$392.81 - $485.53 $213 Million - $264 Million
543,250 Added 57.83%
1,482,676 $695 Million
Q2 2024

Dec 03, 2024
BUY
$392.81 - $485.53 $214 Million - $264 Million
544,625 Added 58.06%
1,482,676 $695 Million
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $213 Million - $264 Million
543,250 Added 57.83%
1,482,676 $695 Million
Q1 2024

Feb 07, 2025
BUY
$407.69 - $446.08 $560,573 - $613,360
1,375 Added 0.15%
939,426 $393 Million
Q1 2024

Dec 06, 2024
BUY
$407.69 - $446.08 $560,573 - $613,360
1,375 Added 0.15%
939,426 $393 Million
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $66.8 Million - $73.1 Million
163,938 Added 21.14%
939,426 $393 Million
Q4 2023

Feb 07, 2025
SELL
$343.0 - $410.68 $28.7 Million - $34.3 Million
-83,547 Reduced 9.73%
775,488 $316 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $28.7 Million - $34.3 Million
-83,547 Reduced 9.73%
775,488 $316 Million
Q3 2023

Feb 07, 2025
BUY
$338.18 - $362.46 $10.8 Million - $11.6 Million
32,080 Added 3.88%
859,035 $299 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $10.8 Million - $11.6 Million
32,080 Added 3.88%
859,035 $299 Million
Q2 2023

Feb 07, 2025
SELL
$314.42 - $351.91 $25.9 Million - $29 Million
-82,280 Reduced 9.05%
826,955 $291 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $25.9 Million - $29 Million
-82,280 Reduced 9.05%
826,955 $291 Million
Q1 2023

Feb 07, 2025
SELL
$283.23 - $323.1 $8.16 Million - $9.31 Million
-28,816 Reduced 3.07%
909,235 $286 Million
Q1 2023

May 15, 2023
SELL
$283.23 - $323.1 $81 Million - $92.4 Million
-285,922 Reduced 23.92%
909,235 $286 Million
Q4 2022

Feb 07, 2025
BUY
$285.76 - $321.48 $70.4 Million - $79.2 Million
246,336 Added 25.96%
1,195,157 $345 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $70.4 Million - $79.2 Million
246,336 Added 25.96%
1,195,157 $345 Million
Q3 2022

Feb 07, 2025
BUY
$273.83 - $305.53 $2.95 Million - $3.29 Million
10,770 Added 1.15%
948,821 $275 Million
Q3 2022

Mar 03, 2023
SELL
$273.83 - $305.53 $67.5 Million - $75.3 Million
-246,336 Reduced 20.61%
948,821 $275 Million
Q3 2022

Nov 14, 2022
BUY
$273.83 - $305.53 $191 Million - $213 Million
698,774 Added 279.46%
948,821 $275 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $32.3 Million - $40.3 Million
137,679 Added 122.53%
250,047 $70.5 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $770,320 - $907,914
-3,479 Reduced 3.0%
112,368 $29.3 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $2.33 Million - $2.94 Million
-13,143 Reduced 10.19%
115,847 $25.4 Million
Q3 2021

Nov 15, 2021
SELL
$181.39 - $202.99 $1.14 Million - $1.28 Million
-6,293 Reduced 4.65%
128,990 $23.4 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $2.69 Million - $3.17 Million
-14,344 Reduced 9.59%
135,283 $27.3 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $1.89 Million - $2.2 Million
-9,136 Reduced 5.75%
149,627 $32.2 Million
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $136 Million - $181 Million
-654,859 Reduced 80.49%
158,763 $37.5 Million
Q3 2020

Nov 16, 2020
SELL
$255.65 - $303.1 $9.69 Million - $11.5 Million
-37,913 Reduced 4.45%
813,622 $221 Million
Q2 2020

Aug 14, 2020
SELL
$225.48 - $295.8 $39.2 Million - $51.4 Million
-173,885 Reduced 16.96%
851,535 $247 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $5.67 Million - $7.04 Million
-28,399 Reduced 2.69%
1,025,420 $244 Million
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $960,916 - $1.29 Million
5,764 Added 0.55%
1,053,819 $231 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $4.97 Million - $5.6 Million
-29,920 Reduced 2.78%
1,048,055 $178 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $4.26 Million - $4.92 Million
-25,854 Reduced 2.34%
1,077,975 $198 Million
Q1 2019

May 15, 2019
SELL
$163.73 - $194.7 $2.12 Million - $2.52 Million
-12,949 Reduced 1.16%
1,103,829 $203 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $43.6 Million - $55.1 Million
-286,756 Reduced 20.43%
1,116,778 $185 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $6.77 Million - $7.78 Million
40,376 Added 2.96%
1,403,534 $271 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $35.4 Million - $41.3 Million
243,077 Added 21.7%
1,363,158 $232 Million
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $156 Million - $182 Million
1,026,874 Added 1101.71%
1,120,081 $183 Million
Q4 2017

Feb 14, 2018
SELL
$137.28 - $155.55 $520,428 - $589,690
-3,791 Reduced 3.91%
93,207 $14 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $14.4 Million - $15.7 Million
96,998
96,998 $14.7 Million

Others Institutions Holding VRTX

# of Institutions
1,806
Shares Held
239M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $99.5B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email